Anfield Capital Management, LLC Cortexyme, Inc. Transaction History
Anfield Capital Management, LLC
- $263 Million
- Q4 2024
A detailed history of Anfield Capital Management, LLC transactions in Cortexyme, Inc. stock. As of the latest transaction made, Anfield Capital Management, LLC holds 26,656 shares of CRTX stock, worth $34,386. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,656Holding current value
$34,386% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CRTX
# of Institutions
40Shares Held
5.27MCall Options Held
90.8KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.2MShares$1.55 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA825KShares$1.06 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny523KShares$674,1230.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA383KShares$493,9170.23% of portfolio
-
Black Rock Inc. New York, NY355KShares$457,6760.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M